Arvinas Inc
Biotechnology
Healthcare
ARVN
73.00 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
7.52
52 week high
28.04
high
7.78
52 week low
0.00
low
7.44
growth
-70.62 %
previous Close
7.53
P/E ratio
market cap
471 M
div yield
0
usd
Jun 2025
qoq
revenue
22.40 M
-88.14 %
net incoming
-61.20 M
-173.82 %
eps
0.00 %
-173.68 %
eps surprise
10.19 %
net profit margin
-273.21 %
-317.00 %
operating incoming
-71.50 M
-200.14 %
net change in cash
33.90 M
273.85 %
cash on hand
115 M
41.85 %
cost of revenue
0.00 %
top top